Benchmark/diagnostics.roche.com/Roche receives CE mark for the first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease¹
Roche receives CE mark for the first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease¹
diagnostics.roche.com/global/en/news-listing/2026/roche-ce-mark-apoe4.htmlblog1450 mots
89.4GEO Score
Excellent : bien optimisé pour la recherche IA
Moyenne du domaine : 91.7
Signaux de citabilité
Forces
Densité de citations
92
Qualité structurelle
77
Diversité du contenu
75
Naturalité
67
Sources citées
65
Optimisation Q&R
61
Autorité réelle des sources
Le classement d'autorité de chaque source citée (au-delà du regex) et le plan d'action détaillé, dans Citead.
Toutes les pages de diagnostics.roche.com
Roche rapidly develops a PCR test for Ebola within six days
blogRoche receives FDA approval for first diagnostic tests to identify HER2
blogRoche report reveals that misconceptions about hepatitis are driving reluctance to test and failure to treat despite rising deaths
blogNew survey demonstrates how diabetes limits day-to
blogRoche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B
blog